Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| PHOE | Phoenix Asia | $20.90 | -$112.22 | -84.30% | 131.3K | $2.9B | $2.31$133.12 |
| AREB | American Rebel | $2.15 | -$3.40 | -61.23% | 1.4M | $44M | $2.04$13,400.00 |
| BTOG | Bit Origin | $2.86 | -$1.18 | -29.18% | 178.7K | $9.1M | $2.58$60.60 |
| ANL | Adlai Nortye | $7.90 | -$2.73 | -25.68% | 428K | $332M | $0.88$11.05 |
| ATOS | Atossa Therapeutics | $6.35 | -$2.13 | -25.13% | 299.1K | $1.1B | $6.16$19.35 |
| IOTR | iOThree | $3.34 | -$1.07 | -24.26% | 64.6K | $11M | $2.24$59.80 |
| DFLI | Dragonfly Energy | $2.52 | -$0.68 | -21.25% | 953K | $39M | $1.50$26.10 |
| SOLT | Volatility Shares Trust - 2x Solana ETF | $4.30 | -$1.12 | -20.61% | 8.4M | - | $4.14$35.30 |
| YEXT | Yext | $5.71 | -$1.46 | -20.32% | 1.9M | $878M | $5.51$9.20 |
| WHLR | Wheeler Real Estate Investment Trust | $3.86 | -$0.90 | -18.91% | 75.7K | $3.3M | $3.76$6,793.50 |
| XPEG | Themes ETF Trust - Leverage Shares 2x Long Xpev Daily ETF | $9.20 | -$2.11 | -18.63% | 18.4K | - | $9.06$15.89 |
| TXXS | Listed Funds Trust - 21Shares 2x Long Sui ETF | $9.30 | -$2.05 | -18.05% | 27.6K | - | $9.00$30.70 |
| BUUU | Buuu Group | $9.42 | -$2.07 | -18.02% | 29.1K | $192M | $3.67$20.76 |
| PHAR | Pharming Group | $17.12 | -$3.35 | -16.36% | 78.1K | $1.4B | $7.50$21.34 |
| VTIX | Virtuix | $5.74 | -$0.98 | -14.58% | 328.1K | $207M | $5.26$92.74 |
| VIVS | VivoSim Labs | $2.52 | -$0.40 | -13.70% | 997.7K | $7.6M | $1.41$21.96 |
| VSA | VisionSys Ai | $2.47 | -$0.37 | -13.03% | 32.4K | $2.2M | $2.18$212.04 |
| HBNB | Hotel101 Global | $7.26 | -$1.05 | -12.63% | 93.9K | $1.9B | $1.55$10.43 |
Related Articles
Featured Article
Can Atossa Therapeutics Stock Keep Climbing?
Cory Renauer|Jun 28, 2021
Investors want to know if this clinical-stage cancer drug developer can keep putting up big gains.
2 Stocks I Bought Last Week, and 1 Stock I Sold
Rick Munarriz|Nov 11, 2020
This Fool bought into a fast-growing sports-first streaming service and a disruptive mattress maker. He also sold a tech stock cashing in on the credibility gap of online search.
3 Technology Stocks I'd Buy Right Now
Jon Quast|Apr 29, 2020
Don't let current economic uncertainty keep you away from these companies with long-term potential.
My Top Growth Stock for 2020
Simon Erickson|Jan 5, 2020
After seven years of New Year's recommendations, my average pick is up 112%. See which growth-style investment I'm tapping next.
Why Zoom Video Communications, PagerDuty, and Yext Slumped Today
Dan Caplinger|Dec 6, 2019
Even on a strong day on Wall Street, poor earnings held some stocks back.
Why Carnival, Tarena International, and Genesco Slumped Today
Dan Caplinger|Jun 5, 2018
Find out which of these stocks took the biggest hit.
Where Will Organovo Holdings, Inc. Be in 5 Years?
Cory Renauer|Dec 3, 2017
Will Organovo unlock the perceived value buried deep in its organ-printing technology by 2022?
Why Tiny Organovo Is Giving Money to Huge Biotech Amgen
Keith Speights|Aug 30, 2017
Organovo is paying Amgen researchers for their ideas on studying 3D bioprinted tissues. It could be money well spent.
Organovo Holdings Revenue Is Growing at a Snail's Pace Compared With Prior Quarters
Keith Speights|Aug 10, 2017
The 3D bioprinting company beat analyst revenue estimates in its fiscal first quarter -- but its losses worsened because of higher spending.
How Risky Is Organovo Holdings, Inc.?
Keith Speights|Jul 18, 2017
Organovo might be less risky than it's been in the past, but this stock still isn't for the faint of heart.
